Has Robert Kennon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,477 in general payments to Robert Kennon, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Kennon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Kennon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Kennon, MD

Orthopaedic Surgery · Middlebury, CTNPI 1235195843

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $33,425 of the $37,477 with a category attached, or 89.2%. Smith+Nephew accounts for 96.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $18,328 and has fallen 99.8% since, to $45 in 2024.

$37,477in general payments, 2019–2025

Across 34 payments — averaging $1102.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$36K
Stryker$1K
Pacira Therapeutics, Inc.$134

What the payments were for

Consulting fees$6382%
Speaking & faculty fees$33,42589%
Travel & lodging$1,7325%
Food & beverage$1,6824%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	22	$36,240
Stryker	11	$1,104
Pacira Therapeutics, Inc.	1	$134

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,477 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024

$370,040

Medicare patients

812

Services billed

6,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	256	$3,454
Meloxicam	143	$283

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Middlebury

John KeggiMiddlebury$264K
Peter WhangNew Haven$1.8M
Paul SethiGreenwich$1.5M
James YueShelton$1.3M
Robert DeveneyDanbury$907K
James PaceFarmington$721K
Isaac MossFarmington$676K
David FrumbergNew Haven$288K
Lauren GeaneyFarmington$263K
Robert StantonFairfield$199K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →